SCHEMBL19862977

SCHEMBL19862977

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5oc6ccccc6c5cc(-c5ccc(-n6c7ccccc7c7ccccc76)cc5)c43)n2)cc1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
ATM Q13315 1/20 0.33
MEN1 O00255 1/20 0.31
POLB P06746 1/20 0.31
TSHR P16473 1/20 0.31
BRCA1 P38398 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B10 Q99714 1/20 0.31
PDGFRB P09619 1/20 0.30
FLT3 P36888 1/20 0.30
SIRT2 Q8IXJ6 1/20 0.30
SIRT1 Q96EB6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863056 0.94 MAPT (0.33) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19862964 0.93 KDM4E (0.33) KDM4EL3MBTL1ALDH1A1ATMMEN1
SCHEMBL19862973 0.93 KDM4E (0.33) KDM4EL3MBTL1ALDH1A1ATMMEN1
SCHEMBL19862891 0.92 KDM4E (0.35) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19862982 0.91 MAPT (0.34) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19862943 0.90 MAPT (0.34) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19863092 0.90 MAPT (0.38) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19863069 0.89 KMT2A (0.34) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19862978 0.89 KDM4E (0.36) KDM4EL3MBTL1ALDH1A1MAPTHPGD
SCHEMBL19862984 0.88 MAPT (0.36) KDM4EL3MBTL1ALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 KDM4E 1039/4885L3MBTL1 622/4885ALDH1A1 242/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 KDM4E 1039/4885L3MBTL1 622/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.